Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clearpoint Neuro Inc (NQ: CLPT )

4.570 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.500 (10)
Ask (Size) 4.940 (1)
Prev. Close 4.570
Today's Range 4.570 - 4.570
52wk Range 4.540 - 11.85
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 59 companies set new 52-week lows. 
Via Benzinga
Top 5 Health Care Stocks That Are Set To Fly In Q2
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga

Performance

YTD
-45.07%
-45.07%
1 Month
-17.66%
-17.66%
3 Month
-32.99%
-32.99%
6 Month
-49.28%
-49.28%
1 Year
-58.34%
-58.34%

More News

Read More
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
ClearPoint Neuro: Q1 Earnings Insights
Via Benzinga
3 High-Potential Small-Cap Stocks for Investors With Strong Stomachs
Via InvestorPlace
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
From ClearPoint Neuro, Inc.
Via GlobeNewswire
3 Healthcare Stocks With Huge Growth Potential
Via InvestorPlace
Earnings Scheduled For March 1, 2023
Via Benzinga
ClearPoint Neuro's Earnings: A Preview
Via Benzinga
ClearPoint Neuro Secures FDA Nod For ClearPoint Prism Neuro Laser Therapy System
Via Benzinga
FDA Approves ClearPoint Neuro's Updated Software For Guidance System For Neurological Procedures
Via Benzinga
Earnings Scheduled For March 1, 2022
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
ClearPoint Neuro: Q2 Earnings Insights
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
ClearPoint Shares Climb as FDA Announced Clearance To Maestro Brain Model Software
Via Benzinga
ClearPoint Neuro's Return On Capital Employed Insights
Via Benzinga
Again, Buy ‘Em
Via Talk Markets
66 Biggest Movers From Friday
Via Benzinga
38 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Recap: ClearPoint Neuro Q1 Earnings
Via Benzinga
ClearPoint Neuro: Q4 Earnings Insights
Via Benzinga
90 Biggest Movers From Yesterday
Via Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.